Tell us how you fit and we will jump you to the right module.
Electrome operates as a hub. Pick the role that fits and we will scroll you to the program that matters to you, with every other program still visible below.
Partnership opportunities, not a directory of existing partners. Select a node to explore the matching program below.
Programs
Ten ways to partner with Electrome.
Healthcare Providers
Integrate FDA-cleared PSWT into postoperative recovery and musculoskeletal pain pathways with clinician facing tooling.
Clinician-directed prescription device program
Study-defined outcome collection, not device telemetry
Reimbursement and ordering support
In practice. A 12 site orthopedic group evaluates a clinician-directed, prescription-only device for post-operative care as a non-opioid adjunct in its postsurgical workflow and reports adherence by service line.
Stock FDA-cleared bioelectric pain therapy, available over-the-counter (OTC), with tiered wholesale pricing and strong unit economics.
Wholesale tiers from 24 to 500+ units
MAP pricing protection and partner dashboard
Co branded merchandising and marketing kit
In practice. A regional pharmacy chain runs a four week endcap pilot, then expands ActiPatch® to 240 stores using the supplied training and merchandising playbook.
Vertical bioelectric platform anchored by FDA-cleared revenue product, an active pipeline, and an institutional biotech IR cadence.
Active round materials and curated data room
Direct line to executive team
Quarterly investor update cadence
In practice. Institutional and family office investors review the data room, attend a quarterly briefing, and follow milestone progress against the pipeline plan.
System wide deployment of bioelectric care pathways with formulary, supply, and analytics integration for IDNs, ACOs, and payers.
Service line bundles for ortho, ob/gyn, and surgical recovery
EHR friendly outcome reporting
Coverage and benefit design support
In practice. A regional IDN evaluates a clinician-directed, prescription-only device for post-operative care in a postsurgical recovery pathway while a payer partner co-designs an outcomes-based pilot.
Potential decentralized studies with consented outcome collection and study-defined adherence measures. ActiPatch® does not transmit device telemetry.
DCT and hybrid trial designs
Wearable adherence and outcome capture
Real world evidence registries
In practice. Illustrative study concept: a contract research organization (CRO) and research network could assess pain outcomes and self-reported wear time, subject to protocol, consent, and review. ActiPatch® supplies no automatic adherence signal.
Every Electrome program is anchored by FDA 510(k) cleared PSWT devices with documented quality system rigor.
AI-native, human-in-the-loop platform
Specialized agents support research and partner workflows while people inspect outputs, approve actions, and retain decision authority.
Non Opioid Pathways
Drug-free, nonthermal PSWT for device-specific labeled pain uses. Any medication changes require advice from the person's own clinician.
Modular Deployment
Commercial devices and approved portal resources are separate from internal AI research workflows. Partner access depends on eligibility and available features.
Clinical Evidence Strategy
Peer-reviewed PSWT literature informs research planning. Any new study requires its own protocol, oversight, and evidence before clinical conclusions.
Scalable Commercialization
Multi channel distribution across DTC, retail, pharmacy, provider, and enterprise with shared partner infrastructure.
Data and Outcomes Infrastructure
Consented outcome collection is a potential study capability, not a ready-to-use reporting service. ActiPatch® does not pair, transmit wear data, or monitor patients.
What Makes Electrome Different
FDA Cleared Foundation
Non thermal, drug-free, noncontact wearable PSWT at 27.12 MHz with 720 hour continuous therapy. No electrodes. Wear directly on the skin with the included tape or a wrap, or over thin clothing; avoid thick fabric.
AI-native, human-in-the-loop platform
Specialized agents support evidence and operational workflows while human reviewers approve actions and retain decision authority.
Modular Deployment
Device, software, AI, and partner facing infrastructure as modules that compose into clinical, retail, or research stacks.
Programmable Future
Bioelectric signal IP and platform APIs designed for the next era of indications beyond chronic pain.
Institutional Trust Layer
FDA 510(k) Cleared
ActiPatch®
Peer Reviewed
Decades of PSWT research
HIPAA Aware
Patient data discipline
WCAG AA
Accessible by design
VA Referenced
Veteran health context
NASA Feasibility Ranking
PSWT ranked first for spaceflight practicality
US Operated
HQ in Honolulu, HI
Ecosystem Outcomes
Decades of bioelectric science, deployed today.
Restrained indicators of the foundation partners build on. No metrics overload.
FDA Cleared Therapeutic Foundation
Anchored by 510(k) cleared PSWT devices in active clinical use.
50+ Years of PSWT Research
Bioelectric and PSWT research lineage informs every program.
Peer-reviewed clinical publications
Across PEMF and adjacent bioelectric mechanisms.
VA Deployment Experience
Veteran health context and deployment relationships.
NASA Feasibility Ranking
A 2020 NASA spaceflight feasibility assessment, based on a literature review, ranked PSWT first among four drug-free approaches for long space missions.